2024-11-04 - Analysis Report
## Danaher Corp (DHR) Stock Analysis

**1. Performance vs S&P 500**

Danaher Corp (DHR) is a global science and technology company that designs, manufactures, and markets a wide range of products and services. It operates through four segments: Life Sciences, Diagnostics, Environmental & Applied Solutions, and Dental. 

* **DHR Cumulative Return:** 217.02%
* **VOO (S&P 500) Cumulative Return:** 131.78%
* **Difference:** 85.24%
* **Relative Deviation:** 39.0% (DHR outperformed S&P 500 significantly, ranking at the 39th percentile based on historical data).

**Alpha & Beta Analysis:**

| Year | CAGR | MDD | Alpha | Beta |
|---|---|---|---|---|
| 2015 | 8.8% | 9.9% | 8.4% | 0.0 |
| 2016 | 9.9% | 8.3% | 0.4% | 1.0 |
| 2017 | 19.9% | 7.6% | 0.5% | 1.0 |
| 2018 | 11.2% | 13.0% | 21.8% | -1.1 |
| 2019 | 65.2% | 8.3% | 34.2% | 2.1 |
| 2020 | 83.2% | 27.8% | 62.9% | 4.1 |
| 2021 | 122.7% | 13.5% | 83.5% | 3.1 |
| 2022 | -96.2% | 24.4% | -50.7% | 2.1 |
| 2023 | -17.8% | 23.5% | -52.3% | -0.5 |
| 2024 | 10.2% | 13.5% | -23.3% | 0.3 |

DHR has generally outperformed the market (Alpha > 0), with high volatility (Beta > 1) and strong performance in 2019-2021. However, it experienced significant drawdowns in 2022-2023.


**2. Recent Price Movement:**

* **Closing Price:** 247.76 
* **5-day Moving Average:** 244.51
* **20-day Moving Average:** 260.38
* **60-day Moving Average:** 267.32

DHR is currently trading below its 5, 20, and 60-day moving averages, indicating a potential downtrend. 

**3. Technical Indicators & Expected Return:**

* **RSI:** 26.02 (Oversold, suggesting a potential bounce)
* **PPO:** -0.79 (Weak momentum, confirming the downtrend)
* **Delta_Previous_Relative_Divergence:** -11.94 (Short-term downtrend, indicating a decline in momentum).
* **Expected Return:** 83.41% (Long-term potential for significant returns compared to S&P 500).

**4. Recent Earnings & Forecast:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-10-22 | 1.13 | 5.80 B$ |
| 2024-07-23 | 1.23 | 5.74 B$ |
| 2024-04-23 | 1.47 | 5.80 B$ |
| 2024-02-21 | 1.46 | 6.41 B$ |
| 2023-10-24 | 1.53 | 5.62 B$ |

* **Most Recent Earnings (2024-10-22):** EPS of 1.13 exceeded analyst estimates of 1.05. Revenue of 5.80B$ also surpassed estimates. 

DHR has shown consistent revenue growth, but EPS has been declining in recent quarters, indicating potential profitability pressure.

**5. Financial Information:**

**1) Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---|---|---|
| 2024-09-30  | $5.80B  | 58.66% |
| 2024-06-30  | $5.74B  | 59.69% |
| 2024-03-31  | $5.80B  | 60.16% |
| 2023-12-31  | $2.69B  | 60.27% |
| 2023-09-30  | $5.62B  | 58.23% |

**2) Capital and Profitability:**

| Quarter | Equity | ROE |
|---|---|---|
| 2024-09-30 | $51.30B | 1.59% |
| 2024-06-30 | $49.90B | 1.82% |
| 2024-03-31 | $53.44B | 2.04% |
| 2023-12-31 | $53.49B | 2.02% |
| 2023-09-30 | $52.41B | 2.15% |

DHR has maintained stable revenue and profit margins. However, ROE has been declining, suggesting potential challenges in generating returns on capital.

**6. News & Recent Issues:**

* **Recent Earnings News:** Refer to news sources such as Shacknews or similar for latest earnings releases and analyst reactions. 
* **Market Outlook:** Check for any recent reports or analyses from financial institutions like Finbold or others, covering market outlook for DHR.
* **Analyst Opinions & Performance Highlights:** Research recent analyst ratings and reports on DHR's performance, noting significant developments and any changes in investment recommendations.

**7. Conclusion:**

DHR has shown strong historical outperformance compared to the S&P 500. However, recent performance has been weak, with the stock trading below key moving averages and indicating potential challenges in profitability. 

**Key Takeaways:**

* DHR has a strong history of outperforming the market but faces recent headwinds.
* Technical indicators suggest oversold conditions and potential for a bounce.
* Earnings reports show consistent revenue growth but declining EPS.
* Long-term potential for significant returns, but short-term outlook is uncertain.

**Recommendations:**

* **Long-Term Investors:**  DHR remains a potential buy for long-term investors seeking growth and diversification.
* **Short-Term Traders:** DHR might be a risky investment due to current market conditions and uncertain short-term outlook.

**Disclaimer:** This analysis is for informational purposes only and does not constitute financial advice. Always conduct thorough research and consult with a financial advisor before making any investment decisions.
